- ￥1700 - 4000
- GeneTex
- 美国
- GTX100619
- 2025年07月10日
- WB, ICC/IF, IHC-P, IHC-Fr, IP, ELISA, IHC, Sandwich ELISA
- Rabbit
- Human, Mouse, Rat, Cat, Dog
企业认证
相关产品推荐更多 >
![PSAP antibody [4D5F4]](https://img1.dxycdn.com/2022/0328/716/6587004547903500453-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant protein encompassing a sequence within the center region of human Vimentin. The exact sequence is proprietary.
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Polyclonal
- 标记物：
Unconjugated
- 适应物种：
Human, Mouse, Rat, Cat, Dog
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Human
- 目录编号：
GTX100619
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Rabbit
- 应用范围：
WB, ICC/IF, IHC-P, IHC-Fr, IP, ELISA, IHC, Sandwich ELISA
- 浓度：
0.11 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点：
Vimentin
- 抗体英文名：
Vimentin antibody
- 抗体名：
Vimentin 抗体
- 规格：
100 μl/25 μl
| 规格： | 100 μl | 产品价格： | ￥4000.0 |
|---|---|---|---|
| 规格： | 25 μl | 产品价格： | ￥1700.0 |
Wild-type (WT) and Vimentin knockout (KO) 293T cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Vimentin antibody (GTX100619) diluted at 1:50000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
Vimentin antibody detects Vimentin protein expression by immunohistochemical analysis.
Sample:Paraffin-Embedded adult mouse retina.
Green: Vimentin protein stained by Vimentin antibody (GTX100619) diluted at 1:250.
Red: beta Tubulin 3/ TUJ1, stained by beta Tubulin 3/ TUJ1 antibody [GT11710] (GTX631836) diluted at 1:500.
Blue: Fluoroshield with DAPI (GTX30920).
Various whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membranes were blotted with Vimentin antibody (GTX100619) diluted at 1:5000 and competitor's antibody diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
*The competitor is not affiliated with GeneTex and does not endorse this product.
Various whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Vimentin antibody (GTX100619) diluted at 1:50000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody. Corresponding RNA expression data for the same cell lines are based on Human Protein Atlas program.
Vimentin antibody detects Vimentin protein at cytoplasm by immunohistochemical analysis.
Sample: Paraffin-embedded mouse colon.
Vimentin stained by Vimentin antibody (GTX100619) diluted at 1:500.
Antigen Retrieval: Citrate buffer, pH 6.0, 15 min
Various whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Vimentin antibody (GTX100619) diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
Non-transfected (–) and transfected (+) 293T whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Vimentin antibody (GTX100619) diluted at 1:20000.
Vimentin antibody detects Vimentin protein at cytoplasm by immunohistochemical analysis.
Sample: Paraffin-embedded mouse intestine.
Vimentin stained by Vimentin antibody (GTX100619) diluted at 1:500.
Antigen Retrieval: Citrate buffer, pH 6.0, 15 min
Vimentin antibody detects Vimentin protein at cell membrane and cytoplasm in rat testis by immunohistochemical analysis.
Sample: Paraffin-embedded rat testis.
Vimentin antibody (GTX100619) diluted at 1:500.
Antigen Retrieval: Citrate buffer, pH 6.0, 15 min
Various whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Vimentin antibody (GTX100619) diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Diao P et al., J Cell Mol Med 2019 (PMID:30950191)
Pei YF et al., Am J Pathol 2019 (PMID:30735628)
Ma C et al., Onco Targets Ther 2019 (PMID:30863115)
Yu CY et al., Biochem Biophys Res Commun 2018 (PMID:30392905)
Chang CY et al., Cell Death Discov 2018 (PMID:30393570)
Hua KT et al., Sci Rep 2017 (PMID:28667334)
Chen HY et al., Cell Physiol Biochem 2018 (PMID:30235439)
Zheng X et al., Int J Oncol 2017 (PMID:28197640)
Hsu CC et al., J Biomed Sci 2016 (PMID:27863490)
Marquez-Vilendrer SB et al., Oncoscience 2016 (PMID:28105457)
Masaru Terasaki et al., J. Clin. Biochem. Nutr. 2018
Hou YY et al., Oncol Lett 2016 (PMID:27313732)
Yin K et al., Oncotarget 2016 (PMID:27014911)
Nakazawa Y et al., Sci Rep 2018 (PMID:29507310)
Lin S et al., Nitric Oxide 2018 (PMID:29522906)
Magnani E et al., Biochim Biophys Acta 2018 (PMID:29466696)
Pon JR et al., Nat Commun 2015 (PMID:26245647)
Pistore C et al., Oncogene 2017 (PMID:28581528)
Wang YY et al., Cancer Chemother Pharmacol 2017 (PMID:28500555)
Chiu JH et al., J Transl Med 2017 (PMID:28472954)
Chen X et al., Tumour Biol 2017 (PMID:28351308)
Tsai CH et al., Sci Rep 2017 (PMID:28195146)
Wang TH et al., Oncotarget 2015 (PMID:26160837)
Li X et al., Am J Cancer Res 2016 (PMID:28042506)
Stefanie B. Marquez-Vilendrer et al., Oncoscience 2016 (Epub)
Lu CW et al., Cancer Lett 2017 (PMID:27940127)
Ling HH et al., Exp Cell Res 2016 (PMID:27914787)
Sridaran D et al., Tumour Biol 2016 (PMID:27460079)
Leyton-Puig D et al., Biol Open 2016 (PMID:27378434)
Li SW et al., Sci Rep 2016 (PMID:27173006)
Yeh SI et al., Invest Ophthalmol Vis Sci 2015 (PMID:25678686)
Hung AC et al., Clin Cancer Res 2016 (PMID:27036136)
Wang S et al., J Biol Chem 2013 (PMID:23880761)
Wei HJ et al., Oncotarget 2014 (PMID:25237908)
Succoio M et al., J Proteomics 2015 (PMID:26206181)
Julia Pon et al., 0 2010
Huang RF et al., Int J Nanomedicine 2015 (PMID:25914533)
Wai-Theng Lee et al., Food and Chemical Toxicology 2015 (PMID:25656647)
Szu-Ting Lin et al., Cellular and Molecular Life Sciences 2015 (PMID:25596698)
Otti GR et al., PLoS One 2014 (PMID:25397403)
Lei M et al., Biomaterials 2014 (PMID:24824581)
Barrette K et al., Br J Dermatol 2014 (PMID:24628329)
Chen JY et al., J Biomed Sci 2013 (PMID:24359494)
Haider S et al., Endocrinology 2014 (PMID:24189144)
Smith A et al., Biotech Histochem 2013 (PMID:24047151)
Chen JY et al., J Nutr Biochem 2013 (PMID:24011924)
Lin ST et al., J Pharm Biomed Anal 2013 (PMID:23425445)
Cho CK et al., J Proteome Res 2010 (PMID:20459121)
Vannier C et al., J Biol Chem 2013 (PMID:23921385)
Hsu HY et al., Evid Based Complement Alternat Med 2012 (PMID:23320038)
Mingjing Zhang et al., Stem Cell Research 2023 (PMID:37178573)
Sun C et al., Oncogenesis 2023 (PMID:36990991)
Chang TM et al., Int J Biol Sci 2023 (PMID:37056937)
Taguchi K et al., J Clin Invest 2022 (PMID:36453545)
Su MT et al., Pharmaceuticals (Basel) 2022 (PMID:36558974)
He S et al., J Virol 2022 (PMID:35758658)
Ni C et al., Nat Commun 2022 (PMID:36207295)
Leung D et al., J Transl Med 2022 (PMID:36463238)
Wuputra K et al., Int J Mol Sci 2022 (PMID:35887129)
Matschke J et al., Front Neurol 2022 (PMID:35785352)
Wang L et al., Bioengineered 2022 (PMID:35609330)
Marlena Brzozowa-Zasada et al., Prz Gastroenterol 2022 (PMID:35664018)
Ching-Chung Ko et al., Int J Mol Sci 2022 (PMID:35743003)
Jia-Huang Chen et al., J Biomed Sci 2022 (PMID:35765067)
Nastaran Mohammadi Ghahhari et al., Nat Commun 2022 (PMID:35440541)
Krutika Deshpande et al., Curr Protoc Stem Cell Biol 2019 (PMID:30720927)
Wojciech Snoch et al., Int J Mol Sci 2021 (PMID:34281292)
Li Xiao et al., Int J Mol Sci 2021 (PMID:34639214)
Kai-Wei Chang et al., Int J Mol Sci 2021 (PMID:34681813)
Zou W et al., J Cell Mol Med 2022 (PMID:35229451)
Pai JT et al., Int J Mol Sci 2022 (PMID:35163593)
Chen YA et al., Sci Rep 2021 (PMID:34789743)
Gaur G et al., Antibiotics (Basel) 2021 (PMID:34827233)
Kawami M et al., Toxicology 2021 (PMID:34425168)
Chen HH et al., iScience 2021 (PMID:34568799)
Lai YW et al., Cells 2021 (PMID:34440660)
Wang LT et al., Cancer Lett 2021 (PMID:34265398)
Wu TT et al., Antioxidants (Basel) 2021 (PMID:34356319)
Buqu? A et al., Nat Commun 2020 (PMID:32732875)
Klein M et al., Front Aging Neurosci 2020 (PMID:32581775)
Wang Y et al., Nat Commun 2021 (PMID:33741957)
Wang J et al., Cancer Manag Res 2021 (PMID:33790645)
Li Y et al., Transl Lung Cancer Res 2021 (PMID:34012797)
Huang R et al., Ann Transl Med 2020 (PMID:32355773)
Hu W et al., JCI Insight 2021 (PMID:33400686)
Chen HY et al., Antioxidants (Basel) 2021 (PMID:33451157)
Zhang D et al., Oncol Rep 2020 (PMID:32323829)
Delgado-Valero B et al., Clin Sci (Lond) 2021 (PMID:33355632)
Lee KY et al., Cells 2020 (PMID:33375719)
Discovery of Lamin B1 and Vimentin as Circulating Biomarkers for Early Hepatocellular Carcinoma
electrophoresis (2DE) and MALDI-TOF/TOF mass spectrometry, our groups have identified lamin B1 (LMNB1) and vimentin (VIM) as promising biomarkers for detection of early HCC. Protein levels of both biomarkers were significantly elevated in cancerous tissues
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
The importance of antibody molecules was first recognized in the 1890s, when it was shown that immunity to tetanus and diphtheria was caused by antibodies against the bacterial exotoxins (1 ). Around the same time, it was shown that antisera
技术资料暂无技术资料 索取技术资料
